Want a deeper scan?
Get a guided tour of your organization’s security posture from an UpGuard team member.


This is a preliminary report on Inspirata’s security posture. If you want in-depth, always up-to-date reports on Inspirata and millions of other companies, start a free trial today. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.
Get the full report

UpGuard Security Rating

/ 950
This is a 0-950 security rating for Inspirata. The higher the rating, the more likely Inspirata has good security practices. For complete visibility of the security posture of Inspirata, start a free trial of UpGuard.

Company info

Florida, United States
Satish Sanan
Last updated
Last updated
Last updated today

Security report for Inspirata

Inspirata is a healthcare technology company specializing in cancer informatics and digital pathology solutions. They provide software platforms and services that enable healthcare providers to manage and analyze cancer-related data, facilitating improved diagnosis, treatment, and research.
Get the full report
Last updated today

Inspirata Data Breaches and Security News

Relevant news, breaches and security articles relating to Inspirata.

More security reports

Compare Inspirata's security performance with other companies.

Leader in Third Party & Supplier Risk Management Software

See how UpGuard shapes up against other platforms in the market.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating
Want a full vendor security report for this company?
Start your free trial and unlock real-time insights to identify and assess vendor risks.